13F Data
13F filer · CIK 1844002

Alerce Investment Management, L.P.

Chicago, IL · filing since Q4 2020 · last filing Feb 14, 2025
Reported value
$56.8M
$-5.5M vs prior
Positions
5
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $5.5M
Top-10 weight
100.0%

Biggest buys vs Q3 2024

No new or increased positions this quarter.

Biggest sells vs Q3 2024

ChangeSecurityShares changeChange %Est. trade value
ReducedVERONA PHARMA PLC-117,880-57.3%$-5.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $253.9MQ1 2021: $226.0MQ2 2021: $184.2MQ3 2021: $146.1MQ4 2021: $98.3MQ1 2022: $59.0MQ2 2022: $53.9MQ3 2022: $103.9MQ4 2022: $86.9MQ1 2023: $75.7MQ2 2023: $76.9MQ3 2023: $58.5MQ4 2023: $75.2MQ1 2024: $95.1MQ2 2024: $51.0MQ3 2024: $62.3MQ4 2024: $56.8M
Q4 2020Q4 2024

Holdings · Q4 2024

#SecuritySharesValueWeight
1ANNEXON INCCOM7,406,024$38.0M66.89%
2AKEBIA THERAPEUTICS INCCOM5,747,906$10.9M19.23%
3VERONA PHARMA PLCSPONSORED ADS88,000$4.1M7.19%
4AMERICAN WELL CORPCOM CL A NEW523,785$3.8M6.69%
5AADI BIOSCIENCE INCCOM659$2.1K0.00%